Discontinued — last reported Q4 '25
Other products — Total revenues
Products & Services · Total revenuesAmgen Other products — Total revenues remained flat by 0.0% to $1.82B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 29.0%, from $1.41B to $1.82B. Over 2 years (FY 2023 to FY 2025), Other products — Total revenues shows an upward trend with a 24.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests successful commercialization or sustained demand for secondary assets, while a decrease may indicate product maturity, loss of exclusivity, or a strategic shift away from these therapeutic areas.
Detailed definition
This metric represents the aggregate gross revenue generated from the company's portfolio of secondary or non-core thera...
Peer comparison
Peers in the biotechnology and pharmaceutical sectors typically report similar 'Other' or 'Miscellaneous' product categories, which are often used to aggregate smaller revenue contributors that do not meet the threshold for individual segment reporting.
amgn_segment_other_products_total_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.47B | $1.73B | $1.48B | $1.59B | $1.17B | $1.17B | $1.17B | $1.17B | $1.41B | $1.41B | $1.41B | $1.41B | $1.82B | $1.82B | $1.82B | $1.82B |
| QoQ Change | — | +17.4% | -14.5% | +7.6% | -26.1% | +0.0% | +0.0% | +0.0% | +19.9% | +0.0% | +0.0% | +0.0% | +29.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | +8.0% | -20.5% | -26.1% | — | — | +19.9% | +19.9% | +19.9% | +19.9% | +29.0% | +29.0% | +29.0% | +29.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Amgen's other products — total revenues?
- Amgen (AMGN) reported other products — total revenues of $1.82B in Q4 2025.
- How has Amgen's other products — total revenues changed year-over-year?
- Amgen's other products — total revenues increased by 29.0% year-over-year, from $1.41B to $1.82B.
- What is the long-term trend for Amgen's other products — total revenues?
- Over 2 years (2023 to 2025), Amgen's other products — total revenues has grown at a 24.4% compound annual growth rate (CAGR), from $4.70B to $7.26B.
- What does other products — total revenues mean?
- The total revenue generated from the company's secondary or non-core therapeutic product lines.